miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma.
Tan YL, Bai ZG, Zou WL, Ma XM, Wang TT, Guo W, Liu J, Li JS, Jie-Yin, Zang YJ, Zhang ZT.
Tan YL, et al. Among authors: liu j.
Clin Res Hepatol Gastroenterol. 2015 Jun;39(3):359-65. doi: 10.1016/j.clinre.2014.09.010. Epub 2014 Dec 17.
Clin Res Hepatol Gastroenterol. 2015.
PMID: 25543521